science Archive
-
January 3, 2019
Vanderbilt experts discuss potential of universal genetic database to balance privacy, law enforcement concerns
The pivotal role that long distance familial genetic searches played in the apprehension of the notorious Golden State Killer — and as a tool in dozens more cases since — has led experts from Vanderbilt University and Vanderbilt University Medical Center to make a provocative proposal about how investigative use of DNA should be regulated. -
April 5, 2018
Study reveals frogs bouncing back in Panama
A new study reports that some Central American frog species are recovering from a deadly fungal epidemic, perhaps because they have better defenses against the pathogen. -
March 15, 2018
Study spots undiagnosed genetic diseases in EHR
Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases. -
February 23, 2017
Team identifies ‘switch’ involved in DNA replication
DNA replication is an extraordinarily complex multi-step process that makes copies of the body’s genetic blueprint. It is necessary for growth and essential to life. Now researchers at the California Institute of Technology (Caltech) and Vanderbilt University have found evidence that one of those steps may involve the telephone-like transmission of electrical signals regulated by a chemical “switch.” -
September 8, 2016
Investigators create ‘Trojan Horse’ to fight Ebola
A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. -
August 11, 2016
Study reveals neurotransmitter glutamate’s molecular structure
Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. -
July 9, 2015
Study could lead to vaccine for mosquito-borne dengue virus
Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.